Sign In

Mark Coles

Kennedy Professor of Immunology, Kennedy Institute of Rheumatology, Founding Fellow and Cellular Life Theme Lead Reuben College, University of Oxford

Mark Coles is a prominent immunologist and the co-founder of Mestag Therapeutics, a biotech company established in 2020 that focuses on developing precision medicines targeting fibroblast subpopulations involved in inflammatory diseases and cancer. He holds the position of Kennedy Professor of Immunology at the Kennedy Institute of Rheumatology, part of the University of Oxford.123

Background and Contributions

  • Academic Role: Mark Coles is affiliated with the Nuffield Department of Orthopaedics and Musculoskeletal Sciences at the University of Oxford, where he conducts research on immune function and human therapeutics.3
  • Mestag Therapeutics: The company aims to create innovative therapies that leverage insights into fibroblast-immune cell interactions. This approach is particularly relevant for patients who do not respond to conventional treatments like checkpoint inhibitors.12

Research Focus

Coles' research primarily revolves around understanding how fibroblasts influence immune responses, which is crucial for developing new treatments for various diseases, including cancer and autoimmune disorders.14 His work has contributed to advancing a pipeline of first-in-class therapeutics aimed at improving patient outcomes in these challenging areas.2

Through his leadership at Mestag Therapeutics, Coles is actively involved in translating complex scientific insights into practical therapeutic applications, underscoring his commitment to addressing unmet medical needs in immunology and oncology.12

Highlights

Jan 7 · linkedin

Hiring: Facility Manager Digital Pathology Omics Core Kennedy Institute of Rheumatology University of Oxford Opportunity to join a dynamic team managing a state-of-art multiplex imaging facility in Oxford with MIBIscope (Ionpath), Cell Dive and Open Top Light Sheet. https://lnkd.in/ehynF_Xf

Oct 16 · linkedin

The Kennedy Institute have a prize studentship program that is fully funded (4 years, 23K stiped/year, 12.2K consumables/year and 2.5K travel funds all tuition and fees are paid). Information on the funding programs please see: https://lnkd.in/e5UE7QVV. Non-clinical DPhil Project information: https://lnkd.in/ehmcqQGm

Related Questions

What are Mark Coles' main research interests at the Kennedy Institute of Rheumatology?
How did Mark Coles get involved in founding Mestag Therapeutics?
What are some of the key projects Mark Coles is currently working on at Mestag Therapeutics?
What is Mark Coles' educational background and how has it influenced his career?
How has Mark Coles' work impacted the field of immunology?
Mark Coles
Mark Coles, photo 1
Mark Coles, photo 2
Add to my network

Location

Greater Oxford Area